is saxenda a glp 1 Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy. This milestone launch based on the recent ANDA approval obtained by Cipla's partner, Orbicular. Cipla Saxenda© – A New Treatment

Trimethyllysine: from carnitine biosynthesis to epigenetics

Heavy drinking also increases the risk of developing cardiovascular conditions such as high blood pressure, heart failure, heart attacks, and strokes

Protocol adherence (consistent application produces better results)

Venous thromboembolism, a particularly relevant risk for lupus patients with antiphospholipid antibodies

For example, extremely high doses of magnesium are more likely to cause diarrhea, while large doses of fiber without adequate fluid can actually worsen constipation and make stool harder to pass

Administration technique proves critical - head tilted slightly forward not back to prevent throat drainage, alternating nostrils with 1-2 minute intervals, avoiding immediate deep sniffing, and allowing adequate mucosal contact time